Received Sep 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | 7+ | F4A7R | IM / RA |
Patient received flu vaccine at today's visit. Patient screened negative for past reactions to flu vaccine prior to administration. After patient received flu vaccine, patient's face turned red and she began coughing, stating that she was seeing spots and her throat was scratchy. This RN informed Drs. who came to the bedside to assess patient. Patient's vitals were obtained and she was provided with water. Patient was asked to remain in room for about 20 minutes for observation and repeat vitals. Vital signs remained stable during this time, patient was provided with a snack, and symptoms and vitals were reassessed every 5 minutes. After observation period, patient stated that symptoms had improved and vital signs had remained stable. Patient was cleared to leave per Dr.
None
None
Clobetasol 0.05% external solution, copper IUD, ketaconazole 2% shampoo, multivitamin with iron-calcium-folic acid, omega-3-dha-epa-dpa-fish oil 1050mg, miralax packet, valacyclovir 1000mg
None
None